Coverage of the GeneVentiv and ReciBioPharm collaboration to advance GENV-HEM toward Phase 1/2 clinical testing.
Hemophilia News Today reported on the collaboration, including ReciBioPharm’s role in development and manufacturing as GeneVentiv advances GENV-HEM from preclinical development toward clinical testing.